Article
eEF2K knockdown synergizes STS to inhibit the angiogenesis of lung adenocarcinoma via TG2/IL-6/VEGFR2 pathway
2022-07-06
Abstract excerpt
<h4>Background: </h4> Lung adenocarcinoma (LUAD) is the most popular type of lung cancer. Eukaryotic elongation factor 2 kinase (eEF2K) is considered to be a carcinogen, and Sulfotanshinone IIA sodium (STS) has been proved to have anticancer effect. However, their role in LUAD and its underlying mechanism remains unclear. <h4>Objective: </h4> To figuring out the roles of eEF2K and STS in angiogenesis of LUAD and t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7db78b8-5d03-5ee8-b9ba-c661e1bbe749
- DOI
- 10.21203/rs.3.rs-1806907/v1
